Intrexon | XON - Interest Income


Intrexon reported $319K in Interest Income for its fiscal quarter ending in June of 2024.





Interest Income Change Date
Arrowhead Research USD 9.69M 637K Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Heron Therapeutics USD 433K 277K Dec/2021
Incyte USD 33.69M 2.93M Mar/2026
Intrexon USD 319K 602K Jun/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.39M 2.52M Dec/2025
MacroGenics USD 1.55M 26K Mar/2026
MannKind USD 1.64M 991K Dec/2025
Merck USD 69M 27M Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Thermo Fisher Scientific USD 258M 258M Dec/2025
Veracyte USD 3.48M 545K Sep/2025
Xencor USD 6.2M 338K Dec/2025